3651 - 3675 of 6230 Results
Title
Year
- Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's disease2021OPENTitle: Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's diseaseJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100817End Page: 100817Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100817Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100817Citation Count: 20
- Deep Learning and fMRI-Based Pipeline for Optimization of Deep Brain Stimulation During Parkinson’s Disease Treatment: Toward Rapid Semi-Automated Stimulation Optimization2024OPENTitle: Deep Learning and fMRI-Based Pipeline for Optimization of Deep Brain Stimulation During Parkinson’s Disease Treatment: Toward Rapid Semi-Automated Stimulation OptimizationJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 12Issue #:Start Page: 589End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2024.3448392Best OA location URL: http://xplorestaging.ieee.org/ielx8/6221039/10325338/10643605.pdf?arnumber=10643605Citation Count: 2
- Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein2022OPENTitle: Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-SynucleinJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 94Issue #: 48Start Page: 16711End Page: 16719Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.2c03183Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.2c03183Citation Count: 18
-
OPENTitle: Hispanic Perspectives on Parkinson’s Disease Care and Research ParticipationJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 81Issue #: 2Start Page: 809End Page: 819Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jad-210231Best OA location URL: https://escholarship.org/uc/item/7sw467pnCitation Count: 17
-
OPENTitle: Genome-wide evaluation of the effect of short tandem repeat variation on local DNA methylationJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol: 33Issue #: 2Start Page: 184End Page: 196Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/gr.277057.122Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10069470Citation Count: 18
-
OPENTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5656509Citation Count: 147
- Reply to: “Refutation of the αSyn‐SAA‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD‐ISS])”2025OPENTitle: Reply to: “Refutation of the αSyn‐SAA‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD‐ISS])”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30272Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30272Citation Count: 0
- Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study2017OPENTitle: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyJournal Name: Schizophrenia ResearchPublisher: Elsevier BVVol: 214Issue #:Start Page: 3End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038Citation Count: 80
-
OPENTitle: Mild cognitive impairment as a risk factor for Parkinson's disease dementiaJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 1056End Page: 1065Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27002Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/264547Citation Count: 144
- Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s Disease2014OPENTitle: Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2014Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/606427Best OA location URL: https://downloads.hindawi.com/journals/pd/2014/606427.pdfCitation Count: 25
- The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease2018OPENTitle: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-34490-9Best OA location URL: https://www.nature.com/articles/s41598-018-34490-9.pdfCitation Count: 143
- Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data2024OPENTitle: Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal dataJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01175-9Best OA location URL: https://escholarship.org/uc/item/31d55222Citation Count: 12
- Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease2022OPENTitle: Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 340End Page: 350Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13414Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mdc3.13414Citation Count: 18
- Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins2018OPENTitle: Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO ProteinsJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/pmic.201700444Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.201700444Citation Count: 44
-
OPENTitle: Olfactory impairment predicts cognitive decline in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 25Issue #:Start Page: 45End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.013Best OA location URL: http://doi.org/10.1016/j.parkreldis.2016.02.013Citation Count: 111
- Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity2018OPENTitle: Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivityJournal Name: Journal of Psychosomatic ResearchPublisher: Elsevier BVVol: 112Issue #:Start Page: 32End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychores.2018.04.002Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/8d94b40b-cb36-4fd4-91a7-d6c0a3ffa5adCitation Count: 16
- Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease2024OPENTitle: Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 5Start Page: 1644End Page: 1652Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae061Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae061/57311350/awae061.pdfCitation Count: 4
- The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism2018OPENTitle: The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 90End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.005Best OA location URL: http://www.prd-journal.com/article/S1353802018301500/pdfCitation Count: 62
-
OPENTitle: Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 371Issue #: 6526Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aaw0843Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8091809Citation Count: 72
-
OPENTitle: LRRK2 activity does not dramatically alter α-synuclein pathology in primary neuronsJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0550-0Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0550-0Citation Count: 37
-
OPENTitle: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainJournal Name: Molecular Therapy - Methods & Clinical DevelopmentPublisher: Elsevier BVVol: 11Issue #:Start Page: 29End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008Best OA location URL: http://www.cell.com/article/S2329050118300895/pdfCitation Count: 17
- MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a2014OPENTitle: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320aJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 278Issue #:Start Page: 185End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4297694Citation Count: 64
-
OPENTitle: Neural closed-loop deep brain stimulation for freezing of gaitJournal Name: Brain StimulationPublisher: Elsevier BVVol: 13Issue #: 5Start Page: 1320End Page: 1322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2020.06.018Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X20301364/pdfCitation Count: 52
- KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity2015OPENTitle: KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicityJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 31Start Page: 9596End Page: 9601Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1505953112Best OA location URL: https://www.pnas.org/content/pnas/112/31/9596.full.pdfCitation Count: 149
-
OPENTitle: Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and agingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41591-025-03831-3Best OA location URL: https://www.nature.com/articles/s41591-025-03831-3.pdfCitation Count: 3